An intrauterine postoperative anti-adhesion membrane, its preparation method and delivery device
Patent Information
- Application Number
- CN202610642293.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-05-11
- Publication Date
- 2026-08-04
AI Technical Summary
其优势在于提供持续的机械支撑,但其本身是异物,可能引起炎症反应、不适或嵌顿,且需要二次手术取出,无法覆盖所有微创面
[0046] Beneficial Effects: This invention uses ABA triblock polymers such as PLA-PEG-PLA as the inner layer and natural hydrogel as the outer rapid hydration layer, ensuring comfort while providing a longer anti-adhesion protection time compared to traditional anti-adhesion materials. This invention has the following advantages: 1) By utilizing the swelling effect of ABA triblock polymers, this invention achieves a small size and easy deployment; 2) Utilizing natural hydrogel as the outer layer provides rapid hydration, reducing deployment time and exhibiting lower cytotoxicity and better biocompatibility; 3) The delivery device reduces deployment difficulty and surgical risks.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] This invention relates to the fields of medical devices and biodegradable biomedical materials, and more particularly to a postoperative anti-adhesion membrane for intrauterine surgery, its preparation method, and delivery device. It is a biodegradable biphasic composite anti-adhesion material and its delivery system used for postoperative anti-adhesion, uterine cavity repair, hemostasis, and local drug delivery in the intrauterine cavity. This invention belongs to the technical field of tissue regeneration medicine and gynecological minimally invasive surgical aids. Background Technology
[0002] Intrauterine adhesions (IUA) are a common gynecological complication, often occurring after procedures such as curettage, hysteroscopic adhesiolysis, and endometrial polyp removal. IUA can lead to menstrual abnormalities, infertility, recurrent miscarriages, and repeated postoperative adhesions, severely impacting female fertility.
[0003] Currently, materials used clinically for preventing or repairing intrauterine adhesions include:
[0004] 1. Hyaluronic acid gel isolators: such as commercially available Hyalobarrier®. Advantages include injectability and the ability to isolate wounds; disadvantages include insufficient mechanical support, susceptibility to being washed away by bodily fluids, and limited residence time.
[0005] 2. Intrauterine Device (IUD): As a physical barrier, it supports the anterior and posterior walls of the uterine cavity, preventing them from adhering together and forming adhesions. It is usually used as an adjunct to other methods, in combination with estrogen medications or anti-adhesion gels. Representative products include traditional round IUDs, uterine-shaped IUDs, or "T"-shaped rings. Its advantage lies in providing continuous mechanical support, but it is a foreign body and may cause inflammatory reactions, discomfort, or embedment. It also requires a second surgery for removal and cannot cover all minimally invasive areas.
[0006] 3. Single hydrogel barrier materials: These materials hydrate quickly but degrade rapidly, lack sufficient mechanical support, and exhibit poor morphological retention in the complex environment of the uterine cavity. Representative products include chitosan / chitosan gels, such as "medical chitosan gel," which only possesses certain antibacterial, hemostatic, and film-forming properties.
[0007] Therefore, there is an urgent clinical need for a biodegradable composite anti-adhesion system that can quickly isolate the wound; expand in body fluids and maintain its shape to adhere to the uterine cavity structure; completely degrade within 7–30 days; and can be precisely delivered with good surgical operability.
[0008] To address the aforementioned needs, this invention proposes a biphase composite membrane system composed of an outer layer of natural polymer hydrogel and an inner layer of expandable block copolymer, which is combined with a dedicated injection delivery device to achieve precise implantation. Summary of the Invention
[0009] Technical problem: The present invention aims to provide a biodegradable composite anti-adhesion material with a biphasic structure and a delivery system for use in postoperative anti-adhesion of the uterine cavity, endometrial repair, intraoperative hemostasis, and local sustained release of drugs.
[0010] Technical solution:
[0011] An intrauterine postoperative anti-adhesion membrane. The anti-adhesion membrane is a biphase composite membrane, which is a biphase system composed of a natural polymer hydrogel outer layer (6) and an expandable block copolymer inner layer (7), forming a biphase structure with gradient hydration function; the natural polymer hydrogel outer layer is used to rapidly hydrate and form an isolation barrier after contact with body fluids.
[0012] The total thickness of the biphase composite membrane is 100~1000μm, and it can expand spontaneously in body fluids and be completely biodegraded within 7-30 days.
[0013] The outer layer material of the natural polymer hydrogel is selected from one or more of gelatin, hyaluronic acid, sodium alginate, chitosan, their derivatives or cross-linked hydrogels; and the thickness of the outer layer is 10~200μm.
[0014] The inner layer of the expandable block copolymer is an ABA-type, AB-type, or BAB-type block copolymer; wherein, segment A is a biodegradable hydrophobic segment selected from polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polytrimethylene carbonate (PTMC), or their copolymers (PLGA); segment B is a hydrophilic segment selected from polyethylene glycol (PEG), polyethylene oxide (PEO), polyvinylpyrrolidone (PNVP), polyacrylic acid (PAA), or their copolymers.
[0015] The expandable block copolymer inner layer is one or more of PCL-PEG-PCL, PLGA-PEG-PLGA, PLA-PNVP-PLA, PGA-PEG-PGA, PLA-PEG-PLA, or PTMC-PEG-PTMC, wherein the number average molecular weight of the PEG segments is not less than 10 kDa, and the molar ratio of segment A to segment B is 0.1:1 to 2.0:1.
[0016] The number-average molecular weight of the PEG segments is not less than 10 kDa, and the block content is 10~90 wt%.
[0017] The expandable block copolymer inner layer is capable of expanding by at least 50% in volume after absorbing body fluids.
[0018] The planar unfolded shape of the biphasic composite membrane is a triangle, trapezoid, rectangle, or a structure that matches the cross-section of the human uterine cavity with rounded corners.
[0019] An injection delivery device for an anti-adhesion membrane after intrauterine surgery, the delivery device comprising: a cervical positioning ring (2), an outer tube (3) and a piston hose pusher (4), the outer tube (3) being a cylindrical soft tube 10-30 cm in length, with graduations on its surface; a slidable piston hose pusher (4) being disposed inside the outer tube (3), the piston hose pusher (4) being marked with a piston hose pusher mark (5); the distal end of the outer tube (3) being a canning area (1), the biphasic composite membrane being pre-loaded inside the outer tube (3) in a coiled or wavy form.
[0020] A method for preparing an intrauterine postoperative anti-adhesion membrane includes the following steps:
[0021] Step 1: Preparation of the inner layer raw material for the biphase composite membrane: ABA / AB / BAB block copolymer;
[0022] Step 2: Preparation of the outer layer material of the biphase composite membrane: natural hydrogel;
[0023] Step 3: Fabricate the inner polymer film using the solvent casting method;
[0024] Step 4: After the inner polymer film absorbs water, it is laid flat on a high vacuum adsorption coating instrument. The natural hydrogel is scraped onto the surface of the polymer film and cured. The process is repeated after flipping the film over.
[0025] Step 5: Dialyze the biphasic membrane to remove the photoinitiator;
[0026] Step Six: Freeze-dry and heat-set the two-phase membrane;
[0027] Step 7: Fold the biphase membrane and place it in the filling area of the delivery device.
[0028] in,
[0029] In step one, the inner block copolymer (100~800 μm) can be of type ABA, AB, or BAB, including:
[0030] Hydrophobic Section A: PLA, PGA, PCL, PTMC, PLGA;
[0031] Hydrophilic B segment: PEG, PEO, PNVP, PAA;
[0032] The number-average molecular weight of segment B is not less than 10 kDa, and the polymers of segment A and segment B...
[0033] Optional structures include one or more triblock polymers such as PLA-PEG-PLA (preferred); PCL-PEG-PCL; PLGA-PEG-PLGA; and PTMC-PEG-PTMC. The inner polymer expands in volume by ≥50% after absorbing water, providing necessary support.
[0034] In step two, the outer natural hydrogel includes gelatin, hyaluronic acid, sodium alginate, chitosan and its derivatives; it can be cured by photocrosslinking (such as GelMA / HAMA), ionic crosslinking (alginic acid), chemical crosslinking, etc.
[0035] In step two, the concentration of the hydrogel should be greater than 10 wt%.
[0036] In step three, the polymer film is dissolved in dichloromethane solvent with a solvent concentration of 100 mg / mL.
[0037] In step three, the thickness of the polymer film should be between 100 and 800 μm.
[0038] In step four, the thickness of the natural hydrogel membrane should be greater than or equal to 20 μm.
[0039] In step five, the biphase membrane should be immersed in deionized water for dialysis.
[0040] In step five, the dialysis time is 3 days.
[0041] In step five, the dialysis fluid exchange time is 6-8 hours.
[0042] In step six, the freezing temperature is -20 ~ -80 ℃.
[0043] In step six, the heat setting temperature is 30 ℃.
[0044] In step six, the heat setting time is 24 hours.
[0045] In step seven, the folding method includes, but is not limited to, W-shaped, C-shaped, or other curved shapes.
[0046] Beneficial Effects: This invention uses ABA triblock polymers such as PLA-PEG-PLA as the inner layer and natural hydrogel as the outer rapid hydration layer, ensuring comfort while providing a longer anti-adhesion protection time compared to traditional anti-adhesion materials. This invention has the following advantages: 1) By utilizing the swelling effect of ABA triblock polymers, this invention achieves a small size and easy deployment; 2) Utilizing natural hydrogel as the outer layer provides rapid hydration, reducing deployment time and exhibiting lower cytotoxicity and better biocompatibility; 3) The delivery device reduces deployment difficulty and surgical risks. Attached Figure Description
[0047] Figure 1 This is a structural diagram of the delivery device;
[0048] Figure 2 This is a schematic diagram of a two-phase composite membrane structure;
[0049] Figure 3 This is a schematic diagram of the unfolded shape of the two-phase membrane and its pre-rolled assembly in the delivery device;
[0050] Figure 4 This is a schematic diagram of the delivery of the entire biphasic membrane in the uterine cavity;
[0051] Figure 5 This is a graph showing the trend of water absorption over time in Example 5;
[0052] Figure 6 This is a fluorescence image of TPC (left) and type I collagen (right) positive control group cells from Example 9;
[0053] Figure 7 This is a fluorescence image of cells in the biphasic composite membrane experimental group of Example 9.
[0054] In the diagram: 1: Canning area, 2: Cervical positioning ring, 3: Outer tube, 4: Piston hose push rod, 5: Piston hose push rod marking, 6: Natural polymer hydrogel outer layer, 7: Expandable block copolymer inner layer, 8: Expanded shape, 9: Loading cross section, 10: Uterus, 11: Uterine wall. Detailed Implementation
[0055] The technical solution of the present invention will be further described in detail below through specific embodiments. However, it should be noted that the following embodiments are only used to describe the content of the invention and do not constitute a limitation on the scope of protection of the present invention.
[0056] An intrauterine postoperative anti-adhesion membrane. The anti-adhesion membrane is a biphase composite membrane, which is a biphase system composed of a natural polymer hydrogel outer layer (6) and an expandable block copolymer inner layer (7), forming a biphase structure with gradient hydration function; the natural polymer hydrogel outer layer is used to rapidly hydrate and form an isolation barrier after contact with body fluids.
[0057] The total thickness of the biphase composite membrane is 100~1000μm, and it can expand spontaneously in body fluids and be completely biodegraded within 7-30 days.
[0058] The outer layer material of the natural polymer hydrogel is selected from one or more of gelatin, hyaluronic acid, sodium alginate, chitosan, their derivatives or cross-linked hydrogels; and the thickness of the outer layer is 10~200μm.
[0059] The inner layer of the expandable block copolymer is an ABA-type, AB-type, or BAB-type block copolymer; wherein, segment A is a biodegradable hydrophobic segment selected from polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polytrimethylene carbonate (PTMC), or their copolymers (PLGA); segment B is a hydrophilic segment selected from polyethylene glycol (PEG), polyethylene oxide (PEO), polyvinylpyrrolidone (PNVP), polyacrylic acid (PAA), or their copolymers.
[0060] The expandable block copolymer inner layer is one or more of PCL-PEG-PCL, PLGA-PEG-PLGA, PLA-PNVP-PLA, PGA-PEG-PGA, PLA-PEG-PLA, or PTMC-PEG-PTMC, wherein the number average molecular weight of the PEG segments is not less than 10 kDa, and the molar ratio of segment A to segment B is 0.1:1 to 2.0:1.
[0061] The number-average molecular weight of the PEG segments is not less than 10 kDa, and the block content is 10~90 wt%.
[0062] The expandable block copolymer inner layer is capable of expanding by at least 50% in volume after absorbing body fluids.
[0063] The planar unfolded shape of the biphasic composite membrane is a triangle, trapezoid, rectangle, or a structure that matches the cross-section of the human uterine cavity with rounded corners.
[0064] An injection delivery device for an anti-adhesion membrane after intrauterine surgery, the delivery device comprising: a cervical positioning ring (2), an outer tube (3) and a piston hose pusher (4), the outer tube (3) being a cylindrical soft tube 10-30 cm in length, with graduations on its surface; a slidable piston hose pusher (4) being disposed inside the outer tube (3), the piston hose pusher (4) being marked with a piston hose pusher mark (5); the distal end of the outer tube (3) being a canning area (1), the biphasic composite membrane being pre-loaded inside the outer tube (3) in a coiled or wavy form.
[0065] A method for preparing an intrauterine postoperative anti-adhesion membrane includes the following steps:
[0066] Step 1: Preparation of the inner layer raw material for the biphase composite membrane: ABA / AB / BAB block copolymer;
[0067] Step 2: Preparation of the outer layer material of the biphase composite membrane: natural hydrogel;
[0068] Step 3: Fabricate the inner polymer film using the solvent casting method;
[0069] Step 4: After the inner polymer film absorbs water, it is laid flat on a high vacuum adsorption coating instrument. The natural hydrogel is scraped onto the surface of the polymer film and cured. The process is repeated after flipping the film over.
[0070] Step 5: Dialyze the biphasic membrane to remove the photoinitiator;
[0071] Step Six: Freeze-dry and heat-set the two-phase membrane;
[0072] Step 7: Fold the biphase membrane and place it in the filling area of the delivery device.
[0073] in,
[0074] In step one, the inner block copolymer (100~800 μm) can be of type ABA, AB, or BAB, including:
[0075] Hydrophobic Section A: PLA, PGA, PCL, PTMC, PLGA;
[0076] Hydrophilic B segment: PEG, PEO, PNVP, PAA;
[0077] The number-average molecular weight of segment B is not less than 10 kDa, and the polymers of segment A and segment B...
[0078] Optional structures include one or more triblock polymers such as PLA-PEG-PLA (preferred); PCL-PEG-PCL; PLGA-PEG-PLGA; and PTMC-PEG-PTMC. The inner polymer expands in volume by ≥50% after absorbing water, providing necessary support.
[0079] In step two, the outer natural hydrogel includes gelatin, hyaluronic acid, sodium alginate, chitosan and its derivatives; it can be cured by photocrosslinking (such as GelMA / HAMA), ionic crosslinking (alginic acid), chemical crosslinking, etc.
[0080] In step two, the concentration of the hydrogel should be greater than 10 wt%.
[0081] In step three, the polymer film is dissolved in dichloromethane solvent with a solvent concentration of 100 mg / mL.
[0082] In step three, the thickness of the polymer film should be between 100 and 800 μm.
[0083] In step four, the thickness of the natural hydrogel membrane should be greater than or equal to 20 μm.
[0084] In step five, the biphase membrane should be immersed in deionized water for dialysis.
[0085] In step five, the dialysis time is 3 days.
[0086] In step five, the dialysis fluid exchange time is 6-8 hours.
[0087] In step six, the freezing temperature is -20 ~ -80 ℃.
[0088] In step six, the heat setting temperature is 30 ℃.
[0089] In step six, the heat setting time is 24 hours.
[0090] In step seven, the folding method includes, but is not limited to, W-shaped, C-shaped, or other curved shapes.
[0091] Example 1: Synthesis of PLA-PEG-PLA polymer
[0092] Method 1: PEG and D,L-lactide monomers were dried in a vacuum at 45 °C for 48 h. PEG and D,L-lactide were added under vacuum or nitrogen atmosphere according to the LA / EO molar ratio. Stannous octoate catalyst was added at 0.1% of the number of hydroxyl groups of the added PEG, and the reaction was carried out in a sealed environment at 130-140 °C for 3-5 days. The product was dissolved in dichloromethane, purified using petroleum ether / anhydrous ethanol (80% / 20% v / v), and then dried in a vacuum atmosphere at 45 °C for 72 h.
[0093] Method 2: PEG and D,L-lactide monomers were dried in a vacuum at 45°C for 48 h. PEG and D,L-lactide were added according to the LA / EO molar ratio. Stannous octoate catalyst was added at 0.1% of the number of hydroxyl groups of the added PEG, and then dissolved in toluene solution at a ratio of 10% m / v with stirring. The reaction was carried out under nitrogen protection. After reacting at 100-110°C for 5-8 days, the toluene solvent was removed, and the product was dissolved in acetone, purified using diethyl ether / ethanol (70% / 30%) or methanol solution, and then dried at 45°C for 48 hours.
[0094] The chemical characterization of the product uses 1 The LA / EO ratio was obtained by integrating the CH3 groups of PLA (1.38 ppm) and the CH2 groups of PEG (3.6 ppm) using ¹H NMR. Measurements were performed at 25 °C using chloroform as the solvent using an Ubbelohde viscometer. The molecular weight dispersion was measured using GPC with polystyrene as an internal standard and tetrahydrofuran as the solvent.
[0095] The specific feed ratio and some product data are shown in Table 1.
[0096] Example 2: Preparation of GelMA outer hydrogel
[0097] Bovine gelatin was dissolved in a buffer solution (e.g., PBS buffer or carbonate buffer) and heated and stirred at 40–50 °C until completely dissolved, yielding a 10% (w / v) gelatin solution. Under continuous stirring and while maintaining the temperature at 40–50 °C, methacrylic anhydride (MA) was slowly added dropwise to the gelatin solution, with an addition rate of 0.6 g MA per 1 g of gelatin, thus obtaining highly substituted GelMA. Throughout the reaction, the pH of the reaction system was maintained within the range of 7–8. The reaction was carried out for 1–3 h. After the reaction was completed, the reaction solution was diluted with PBS buffer or deionized water to terminate the reaction. The reaction solution was then dialyzed in a dialysis bag with a molecular weight cutoff of 12–14 kDa to remove unreacted MA and other impurities. Finally, the purified solution was freeze-dried to obtain GelMA lyophilized powder, which was stored under dry conditions.
[0098] Example 3: Fabrication process of a two-phase membrane
[0099] First, the PLA-PEG-PLA matrix membrane was soaked in deionized water for 1 hour to ensure full hydration. Then, it was removed, and the free water adhering to the membrane surface was blotted away with filter paper. A high-concentration GelMA solution containing the photoinitiator LAP (0.05–0.1% (w / v)) was uniformly dropped onto the moistened matrix membrane surface. Using a high-vacuum adsorption coating apparatus with a blade gap of 30 μm, the solution was coated into a smooth, thin layer. Immediately after coating, the membrane was irradiated with a 405 nm wavelength UV light source for 30 seconds to crosslink and cure the GelMA layer. The membrane was then flipped over, and the above dropping, coating, and photocuring steps were repeated on the other side. After curing, the resulting biphase membrane was immersed in deionized water to remove residual LAP photoinitiator. Finally, the membrane was freeze-dried and heat-set to obtain the final product.
[0100] Example 4: Swelling Performance Test
[0101] Sample membranes with a thickness of 400–500 μm prepared in Example 3 were placed in PBS buffer at 37 ℃. The size change of the sample membrane over time during the immersion process was recorded. Two parallel samples were set up for each experiment, and the test data were taken as the average of the two. Except for the different LA / EO ratio in PLA-PEG-PLA, the concentration of the outer GelMA hydrogel of all test samples was kept consistent. The specific ratio parameters are shown in Table 2.
[0102] Example 5: Water Absorption Performance Test
[0103] Take the sample membrane with a thickness of 400–500 μm prepared in Example 3 and weigh its initial dry mass (M0). Then, immerse the sample membrane in PBS buffer at 37°C. Remove the sample at a predetermined time point, gently blot off excess liquid with filter paper, and immediately weigh its wet mass (M). t Water absorption can be calculated using the formula (M). t The result was calculated as (-M0) / M0×100%. Two parallel samples were set up for each experiment, and the final data are expressed as the average. Except for the different LA / EO ratio in PLA-PEG-PLA, the concentration of the outer GelMA hydrogel was kept consistent for all tested samples. The relationship between water absorption and time is shown in the figure. Figure 5 As shown.
[0104] Example 6: In vitro degradation test
[0105] A sample membrane with a thickness of 400–500 μm and a PLA-PEG-PLA composition of LA / EO = 0.74, prepared in Example 3, was immersed in a container containing PBS buffer (initial pH 7.23). The container was then placed in a constant-temperature shaker at 37 ℃ and 100 rpm for incubation. Throughout the experimental period, samples were periodically taken and the following parameters were measured: 1) changes in the wet mass of the sample; 2) changes in solution viscosity (measured using a suitable viscometer); and 3) changes in solution pH. To simulate a long-term body fluid exchange environment, the PBS buffer in the system was completely replaced with a fresh, equal volume of buffer every 7 days. Detailed test data are recorded in Table 3.
[0106] Example 7: In vitro cytotoxicity test
[0107] To evaluate the biocompatibility of the biphasic composite membrane, its effect on cell proliferation was determined using the standard MTT assay. The specific method is as follows: The sample membrane (LA / EO = 0.74) prepared in Example 3 was cut into discs with a diameter of approximately 5 mm. The extract was prepared according to the medical device biological evaluation standard (ISO 10993-5). The membrane discs were immersed in cell culture medium containing 10% fetal bovine serum (extraction ratio 0.2 g / mL) and extracted at 37 ℃ and 5% CO2 for 72 h. The extract was then collected and filtered for sterilization. Using conventionally cultured L929 mouse fibroblasts as a model, cells were cultured at a density of 1 × 10⁶ cells per well. 4Cells were seeded at a density of [number] cells / well in 96-well plates and cultured for 24 h to allow cell adhesion. The original culture medium was then discarded, and fresh culture medium (negative control), culture medium containing 10% DMSO (positive control), and the extract of the aforementioned material were added to each well. After further culturing for 24 h and 48 h, MTT solution was added to each well, and after incubation for 4 h, the supernatant was discarded, and dimethyl sulfoxide (DMSO) was added. The mixture was shaken and the absorbance was measured at 570 nm using a microplate reader. The relative cell viability (%) was calculated as: (Experimental group absorbance / Negative control group absorbance) × 100%. The results showed that, compared with the negative control group, the relative cell viability in the sample extract treatment groups was higher than 95%, demonstrating that the material had no significant cytotoxicity and good biocompatibility.
[0108] Example 8: Evaluation of Endometrial Epithelial Cell-Specific Toxicity
[0109] Given that the biphasic composite membrane is intended for use in the uterine cavity environment, to further verify its biosafety to target organ cells, a direct contact culture test was conducted using human endometrial epithelial cell lines. The membrane prepared in Example 3 was sterilized with ethylene oxide and placed at the bottom of a 24-well plate. Human endometrial epithelial cells were cultured at a density of 5 × 10⁶ cells per well. 4 Cells were directly seeded at a density of [number] cells onto the membrane surface and in wells without material (control group), and cultured in complete culture medium at 37°C and 5% CO2. Cell viability was assessed using a CCK-8 assay kit on days 1, 3, and 5. Specifically, culture medium containing 10% CCK-8 reagent was added to each well, and after incubation for 2 hours, the supernatant was transferred to a new 96-well plate, and absorbance was measured at 450 nm. Simultaneously, on day 3, a live / dead cell double staining kit was used for observation: a staining working solution containing calcein AM and propidium iodide (PI) was added, and after incubation in the dark for 30 minutes, observation was performed under a fluorescence microscope. Live cells (with normal esterase activity) showed green fluorescence, while dead cells (with loss of membrane integrity) showed red fluorescence. Results showed that, compared with the control group, there was no significant difference in cell viability at any time point in the experimental group (p > 0.05), and a large number of live cells were visible under fluorescence, with only a few dead cells observed, exhibiting the same morphology as the control group. This result confirms that the biphasic composite membrane has no significant toxicity to endometrial epithelial cells and is suitable for intrauterine application.
[0110] Example 9: Cell Adhesion Experiment
[0111] To verify the cell-adhesion-free design characteristics of the biphasic composite membrane, the inhibitory effect of the material surface on cell adhesion was investigated. The membrane prepared in Example 3 was fixed in 24-well plates, with untreated tissue culture plastic (TCP) plates and plates pre-coated with type I collagen (10 μg / cm²) serving as strong adhesion positive controls. Human uterine fibroblasts were cultured at 2 × 10⁶ cells per well.4 Cells were seeded at a density of 1000 mg / L on the surface of each group and cultured at 37°C and 5% CO2 for 4 h, a period of time usually sufficient for cells to adhere and spread on a suitable surface. After incubation, the culture medium was carefully aspirated, and the wells were gently washed three times with pre-warmed PBS buffer to remove all unattached cells. Then, fresh complete culture medium was added to each well, and the number of viable cells adhering to the material surface was determined using the MTT assay, following the same procedure as in Example 7. Furthermore, after 4 h of culture, the morphology of the cells on the material surface was observed directly under a microscope. The results showed that on the surface of the positive control group (TCP and collagen-coated groups), the cells were fully spread, exhibiting a typical spindle or polygonal shape (see Example 7). Figure 6 ); however, no visible adhesion cells were observed on the surface of the biphasic composite membrane experimental group (see Figure 7 This proves that the surface of the biphasic composite membrane can effectively resist cell adhesion and possesses the designed non-adhesion function.
[0112] Table 1. Feed-to-yield ratio, dispersion, and viscosity-average molecular weight statistics of LA / EO polymers with different proportions.
[0113] 1.5 1.22 1.61 1.3 1.05 1.51 1 0.91 1.49 0.9 0.82 1.16 0.8 0.74 1.12 0.7 0.64 1.29 0.6 0.57 1.43 0.5 0.43 1.57 0.4 0.38 1.63
[0114] Table 2. Changes in Swelling Dimensions
[0115] Sample 1 1.4*1.8*454 2.4*3.1*679 2.6*3.2*789 2.7*3.3*789 2.7*3.3*832 2.75*3.4*895 2.8*3.5*910 2.8*3.5*922 Sample 2 1.4*1.8*421 2.2*2.9*612 2.3*3.1*681 2.4*3.2*655 2.5*3.3*644 2.55*3.4*653 2.6*3.2*766 2.6*3.2*781 Sample 3 1.4*1.8*448 1.9*2.5*596 2.1*2.7*577 2.2*2.8*601 2.3*2.9*589 2.3*3*617 2.4*3.1*618 2.4*3.1*597 Sample 4 1.4*1.8*462 1.7*2.1*513 1.8*2.2*527 1.8*2.2*543 1.9*2.3*532 2*2.4*554 2*2.4*578 2*2.4*566 Sample 5 1.4*1.8*418 1.45*1.9*440 1.5*1.9*460 1.55*2*464 1.6*2.1*473 1.7*2.2*487 1.8*2.3*521 1.8*2.3*532
[0116] Note: The dimensional variation parameters in Table 2 are width (cm) * length (cm) * thickness (μm). The LA / EO ratios of samples 1-5 are 0.38, 0.57, 0.74, 0.91, and 1.22, respectively.
[0117] Table 3 Degradation test data
[0118] 1 7.12 3.2 0.999 1.04 1 7.13 3.149606299 0.978 1.04 3 7.05 6.225680934 0.867 1.04 3 7.06 5.303030303 0.837 1.04 5 7.02 10.22727273 0.90 1.04 5 7.01 10.07462687 0.856 1.04 7 6.96 13.7037037 0.875 1.04 7 6.95 13.86861314 0.845 1.04 10 7.21 13.50364964 0.744 1.04 10 7.21 14.38596491 0.731 1.04 14 7.17 24.24242424 0.724 1.04 14 7.15 24.59546926 0.696 1.04
[0119] The above examples are only for illustrating the technical concept and features of the present invention, and are intended to enable those skilled in the art to understand the content of the present invention and to apply it accordingly. They should not be used to limit the scope of protection of the present invention. All equivalent changes or modifications made according to the spirit and essence of the present invention should be covered within the scope of protection of the present invention.
Claims
1. A postoperative anti-adhesion membrane for the uterine cavity. Its characteristics are: The anti-adhesion membrane is a biphase composite membrane. The biphase composite membrane is a biphase system composed of a natural polymer hydrogel outer layer (6) and an expandable block copolymer inner layer (7), forming a biphase structure with gradient hydration function. The natural polymer hydrogel outer layer is used to quickly hydrate and form an isolation barrier after contact with body fluid.
2. The intrauterine postoperative anti-adhesion membrane according to claim 1. Its characteristics are: The total thickness of the biphase composite membrane is 100~1000μm, and it can expand spontaneously in body fluids and be completely biodegraded within 7-30 days.
3. The intrauterine postoperative anti-adhesion membrane according to claim 1. Its characteristics are: The outer layer material of the natural polymer hydrogel is selected from one or more of gelatin, hyaluronic acid, sodium alginate, chitosan, their derivatives or cross-linked hydrogels; and the thickness of the outer layer is 10~200μm.
4. The intrauterine postoperative anti-adhesion membrane according to claim 1. Its characteristics are: The inner layer of the expandable block copolymer is an ABA-type, AB-type, or BAB-type block copolymer; wherein, segment A is a biodegradable hydrophobic segment selected from polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polytrimethylene carbonate (PTMC), or their copolymers (PLGA); segment B is a hydrophilic segment selected from polyethylene glycol (PEG), polyethylene oxide (PEO), polyvinylpyrrolidone (PNVP), polyacrylic acid (PAA), or their copolymers.
5. The intrauterine postoperative anti-adhesion membrane according to claim 1. Its characteristic is that... The expandable block copolymer inner layer is one or more of PCL-PEG-PCL, PLGA-PEG-PLGA, PLA-PNVP-PLA, PGA-PEG-PGA, PLA-PEG-PLA, or PTMC-PEG-PTMC, wherein the number average molecular weight of the PEG segments is not less than 10 kDa, and the molar ratio of segment A to segment B is 0.1:1 to 2.0:
1.
6. The intrauterine postoperative anti-adhesion membrane according to claim 5. Its characteristic is that... The number-average molecular weight of the PEG segments is not less than 10 kDa, and the block content is 10~90 wt%.
7. The intrauterine postoperative anti-adhesion membrane according to claim 1. Its characteristic is that... The expandable block copolymer inner layer is capable of expanding by at least 50% in volume after absorbing body fluids.
8. The intrauterine postoperative anti-adhesion membrane according to claim 1. Its characteristics are... The planar unfolded shape of the biphasic composite membrane is a triangle, trapezoid, rectangle, or a structure that matches the cross-section of the human uterine cavity with rounded corners.
9. An injection delivery device for the intrauterine postoperative anti-adhesion membrane according to any one of claims 1-8, characterized in that, The delivery device includes: a cervical positioning ring (2), an extracorporeal tube (3) and a piston hose pusher (4). The extracorporeal tube (3) is a cylindrical soft tube with a length of 10-30 cm and has a scale on its surface. The slidable piston hose pusher (4) is located inside the extracorporeal tube (3) and is marked with a piston hose pusher mark (5). The distal end of the extracorporeal tube (3) is a filling area (1), and the biphase composite film is pre-loaded inside the extracorporeal tube (3) in a curled or wavy form.
10. A method for preparing an intrauterine postoperative anti-adhesion membrane, characterized in that... Includes the following steps: Step 1: Preparation of the inner layer raw material for the biphase composite membrane: ABA / AB / BAB block copolymer; Step 2: Preparation of the outer layer material of the biphase composite membrane: natural hydrogel; Step 3: Fabricate the inner polymer film using the solvent casting method; Step 4: After the inner polymer film absorbs water, it is laid flat on a high vacuum adsorption coating instrument. The natural hydrogel is scraped onto the surface of the polymer film and cured. The process is repeated after flipping the film over. Step 5: Dialyze the biphasic membrane to remove the photoinitiator; Step Six: Freeze-dry and heat-set the two-phase membrane; Step 7: Fold the biphase membrane and place it in the filling area of the delivery device.
